335 related articles for article (PubMed ID: 28843780)
1. Epidemiology of estrogen and dementia in women with Down syndrome.
Schupf N; Lee JH; Pang D; Zigman WB; Tycko B; Krinsky-McHale S; Silverman W
Free Radic Biol Med; 2018 Jan; 114():62-68. PubMed ID: 28843780
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy to maintain cognitive function in women with dementia.
Hogervorst E; Yaffe K; Richards M; Huppert F
Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
[TBL] [Abstract][Full Text] [Related]
3. Onset of dementia is associated with age at menopause in women with Down's syndrome.
Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R
Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653
[TBL] [Abstract][Full Text] [Related]
4. Oophorectomy, estrogen, and dementia: a 2014 update.
Rocca WA; Grossardt BR; Shuster LT
Mol Cell Endocrinol; 2014 May; 389(1-2):7-12. PubMed ID: 24508665
[TBL] [Abstract][Full Text] [Related]
5. Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome.
Schupf N; Winsten S; Patel B; Pang D; Ferin M; Zigman WB; Silverman W; Mayeux R
Neurosci Lett; 2006 Oct; 406(3):298-302. PubMed ID: 16926067
[TBL] [Abstract][Full Text] [Related]
6. Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?
Mills ZB; Faull RLM; Kwakowsky A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834617
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy for cognitive function in postmenopausal women.
Lethaby A; Hogervorst E; Richards M; Yesufu A; Yaffe K
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003122. PubMed ID: 18254016
[TBL] [Abstract][Full Text] [Related]
8. Future therapeutic developments of estrogen use.
Fillit H
J Clin Pharmacol; 1995 Sep; 35(9S):25S-28S. PubMed ID: 8530715
[TBL] [Abstract][Full Text] [Related]
9. Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials.
Barrett-Connor E; Laughlin GA
Semin Reprod Med; 2009 May; 27(3):275-82. PubMed ID: 19401958
[TBL] [Abstract][Full Text] [Related]
10. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
11. Age at onset of dementia and age of menopause in women with Down's syndrome.
Cosgrave MP; Tyrrell J; McCarron M; Gill M; Lawlor BA
J Intellect Disabil Res; 1999 Dec; 43 ( Pt 6)():461-5. PubMed ID: 10622361
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and breast cancer: revisiting the issues.
DeGregorio MW; Taras TL
J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
[TBL] [Abstract][Full Text] [Related]
13. Action of estrogens in the aging brain: dementia and cognitive aging.
Henderson VW
Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
[TBL] [Abstract][Full Text] [Related]
14. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and Alzheimer's disease: the story so far.
Cholerton B; Gleason CE; Baker LD; Asthana S
Drugs Aging; 2002; 19(6):405-27. PubMed ID: 12149049
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and cognition: systematic review and meta-analysis.
LeBlanc ES; Janowsky J; Chan BK; Nelson HD
JAMA; 2001 Mar; 285(11):1489-99. PubMed ID: 11255426
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
19. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.
Granholm AC; Ford KA; Hyde LA; Bimonte HA; Hunter CL; Nelson M; Albeck D; Sanders LA; Mufson EJ; Crnic LS
Physiol Behav; 2002 Nov; 77(2-3):371-85. PubMed ID: 12419414
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on the benefits of HRT in menopausal women.
Palacios S
Maturitas; 1999 Nov; 33 Suppl 1():S1-13. PubMed ID: 10661610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
